UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$4.78B |
| 2 |
NVIDIA
NVDA
|
+$3.34B |
| 3 |
Apple
AAPL
|
+$2.76B |
| 4 |
UBS Group
UBS
|
+$2.65B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.88B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
+$4.03B |
| 2 |
iShares Broad USD Investment Grade Corporate Bond ETF
USIG
|
+$2.25B |
| 3 |
Pinduoduo
PDD
|
+$1.4B |
| 4 |
Linde
LIN
|
+$919M |
| 5 |
Prologis
PLD
|
+$865M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.34% |
| 2 | Healthcare | 12.59% |
| 3 | Financials | 12.08% |
| 4 | Consumer Discretionary | 10.26% |
| 5 | Communication Services | 8.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CLCO
2676
DELISTED
Cool Company
CLCO
| $171K | ﹤0.01% |
+14,552
| New | +$168K |
|
|
JKS
2677
JinkoSolar
JKS
$787M
| $169K | ﹤0.01% |
+8,161
| New | +$201K |
|
|
NYXH
2678
Nyxoah
NYXH
$140M
| $160K | ﹤0.01% |
+22,900
| New | +$217K |
|
2679
Biomea Fusion
BMEA
$90.4M
| $159K | ﹤0.01% |
35,429
+23,829
| +205% | +$242K |
|
2680
Entrada Therapeutics
TRDA
$257M
| $150K | ﹤0.01% |
+10,512
| New | +$149K |
|
2681
Similarweb
SMWB
$635M
| $148K | ﹤0.01% |
+19,050
| New | +$148K |
|
2682
Alta Equipment Group
ALTG
$201M
| $135K | ﹤0.01% |
+16,802
| New | +$170K |
|
|
SNCY
2683
DELISTED
Sun Country Airlines
SNCY
| $134K | ﹤0.01% |
+10,658
| New | +$131K |
|
2684
ALX Oncology
ALXO
$264M
| $132K | ﹤0.01% |
+21,823
| New | +$268K |
|
|
CRDL
2685
Cardiol Therapeutics
CRDL
$133M
| $111K | ﹤0.01% |
+55,000
| New | +$117K |
|
2686
Scilex Holding
SCLX
$48M
| $109K | ﹤0.01% |
+1,608
| New | +$67.8K |
|
2687
1stdibs.com
DIBS
$152M
| $105K | ﹤0.01% |
+23,361
| New | +$128K |
|
2688
Sociedad Química y Minera de Chile
SQM
$19.5B
| $87.8K | ﹤0.01% |
+2,154
| New | +$99.5K |
|
2689
Black Diamond Therapeutics
BDTX
$98M
| $86.7K | ﹤0.01% |
+18,600
| New | +$99.8K |
|
2690
CS Disco
LAW
$282M
| $81.6K | ﹤0.01% |
+13,688
| New | +$94.6K |
|
2691
Absci
ABSI
$1.18B
| $73.5K | ﹤0.01% |
+23,850
| New | +$111K |
|
|
NOAH
2692
Noah Holdings
NOAH
$592M
| $65.3K | ﹤0.01% |
+6,770
| New | +$83.5K |
|
|
MOMO
2693
Hello Group
MOMO
$875M
| $62.5K | ﹤0.01% |
+10,212
| New | +$59.6K |
|
2694
ProShares S&P 500 Dividend Aristocrats ETF
NOBL
$11.9B
| $61.5K | ﹤0.01% |
+1,280
| New | +$62.7K |
|
2695
Monte Rosa Therapeutics
GLUE
$1.85B
| $58.3K | ﹤0.01% |
+15,600
| New | +$79.5K |
|
2696
Gaotu Techedu
GOTU
$415M
| $48K | ﹤0.01% |
+9,800
| New | +$61.6K |
|
2697
Bilibili
BILI
$7.87B
| $43.1K | ﹤0.01% |
+2,793
| New | +$38.9K |
|
2698
Immunocore
IMCR
$1.7B
| $41.5K | ﹤0.01% |
1,224
-92,893
| -99% | -$4.74M |
|
2699
Franklin FTSE Brazil ETF
FLBR
$537M
| $40.2K | ﹤0.01% |
+2,418
| New | +$44.7K |
|
|
VNET
2700
VNET Group
VNET
$1.82B
| $31.3K | ﹤0.01% |
+14,931
| New | +$28.6K |
|
Similar funds
UBS AM's Q2 2024 Portfolio in Review
As of Q2 2024, UBS AM held 2,913 positions worth $349B, up 24% from $281B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
UBS AM deployed $57B of net new capital in Q2 2024, opening 370 new positions and adding to 2,061 existing holdings. Its largest new stake was UBS Group: 89,043,128 shares worth $2.63B.
By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 32% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was iShares Core MSCI EAFE ETF, an estimated $4.03B trimmed.
- UBS AM's largest Q2 2024 buy was UBS Group: 89,043,128 shares worth $2.63B.
- UBS AM added most to Microsoft in Q2 2024, an estimated $4.78B increase.
- UBS AM's biggest Q2 2024 reduction was iShares Core MSCI EAFE ETF, cutting an estimated $4.03B.
- UBS AM fully exited iShares Broad USD Investment Grade Corporate Bond ETF in Q2 2024, selling an estimated $2.25B.
- UBS AM's ten largest holdings make up 31% of its $349B portfolio in Q2 2024.
- UBS AM opened 370 new positions and closed 119 in Q2 2024.
- UBS AM's portfolio value rose 24% quarter-over-quarter to $349B.
Based on UBS AM's 13F filing for Q2 2024, filed 14 Aug 2024.